Ko te kitenga whakakotahitanga o EBV-VCA-IGA, EBV-EA-IGA me EB-NA1-IgA ka kapi katoa i te hihinga ira EBV, e pai ake ai te aro me te motuhake o te kitenga mate pukupuku nasopharyngeal.

rongo2 (1)

Ko te mate pukupuku nasopharyngeal (nay-zoh-fuh-RIN-jee-ul) he mate pukupuku e puta ana i roto i te nasopharynx, kei muri i to ihu me runga ake i te tuara o to korokoro.
He onge te mate pukupuku nasopharyngeal i te United States.He maha atu nga waahi ka puta ki etahi atu waahi o te ao - ina koa ki te tonga-tonga o Ahia.

Ko te mate pukupuku nasopharyngeal he uaua ki te kite wawe.Ko te mea pea ko te nasopharynx ehara i te mea ngawari ki te tirotiro me nga tohu o te mate pukupuku nasopharyngeal e rite ana ki era atu o nga ahuatanga tino noa.
Ko te mate pukupuku nasopharyngeal te nuinga ka puta i roto i nga taangata pakeke me nga taangata kua neke ake i te 40 tau te pakeke, a he tino kitea nga ahuatanga o te rohe me te whanau, a ko te reiti mate i Guangdong kei te tuatahi i Haina, e mohiotia ana ko "Guangdong mate pukupuku".

1.Ko nga Aratohu mo te Whakamatau me te maimoatanga o te mate pukupuku Nasopharyngeal

I roto i te 2021 Guidelines for the Diagnosis and Treatment of Nasopharyngeal Carcinoma, te Chinese Society of Clinical Oncology(CSCO) i whakauru i nga tikanga serological detection i roto i te Class I nga taunakitanga mo te mate pukupuku o te nasopharyngeal carcinoma, me te tohu ko te huinga o te EB-VCA-IgA. me te EB-NA1-IgA EB-virus antibodies ka taea te whakanui ake i te tere o te mate o te mate pukupuku nasopharyngeal i te 3 nga wa (21% ~ 79%) me te whakaiti i te mate o te mate i te 88%!Ko te 2019 Expert Consensus on the Clinical Application of Markers for Nasopharyngeal Carcinoma i tohu ano ko te EBV-EA-IgA he tohu mo te mate EBV tata nei, he kaha te tipu o te EBV, me te tino tohu motuhake, a he maha nga wa e whakamahia ana mo te tirotiro mate pukupuku nasopharyngeal. me te tātaritanga wawe.

rongo2 (2)

Ko te rangahau e whakaatu ana ko nga kitenga whakakotahi e toru o EBV-VCA-IGA, EBV-EA-IGA me EB-NA1-IgA ka kapi katoa i te hihinga ira EBV, e pai ake ana te maarama me te motuhake o te kitenga mate pukupuku nasopharyngeal, ka whakaiti i te kitenga ngaro, ka whakarite i te te tika o te matapae mate, me te matapae i te puta mai o te mate 5-10 tau i mua, e tika ana mo te tirotiro mate pukupuku nasopharyngeal nui.

2.Ko te VCA-IgA + EA-IgA + NA1-IgA i hangaia e Beijing Beier ka taea te whakarato i te kawa tohu moata mo te Nasopharyngeal Carcinoma.

Matūriki matūriki immuno matū tikanga luminescence

Ingoa Hua Whakapoto
EB huaketo VCA-IgA kete kimi parepare EB-VCA-IgA
EB huaketo EA-IgA kete kimi parepare EB-EA-IgA
EB huaketo NA1-IgA kete kimi pareketo EB-NA1-IgA

Tikanga Elisa:

Ingoa Hua Whakapoto
EB huaketo VCA-IgA Elisa kete EB-VCA-IgA
EB huaketo EA-IgA Elisa kete EB-EA-IgA
EB huaketo NA1-IgA Elisa kete EB-NA1-IgA

3.Mahinga Hua

Ko te kete whakamatautau VCA-IgA i hangaia e Beijing Beier ka taea te whakakapi i te kete paerewa EU mo te kitenga wawe me te tirotiro i te mate pukupuku nasopharyngeal.
Ko te British Medical Journal (BMJ) (te take paanga 16.378) Ko tetahi o nga hautaka rongoa rongonui e wha o te ao.I roto i te 2017, i whakaputaina e te roopu rangahau he pepa i roto i te British Medical Journal (BMJ) "Te Aromatawai o nga kete VCA-IgA ELISA recombinant e whitu mo te tohu o te mate pukupuku nasopharyngeal i Haina: he whakamatautau-whakamatautau".
I roto i tenei pepa, 200 nga turoro me te mate pukupuku nasopharyngeal (NPC) me te 200 nga tauira serum tangata (SYSUCC) mai i te Sun Yat-sen University Cancer Center i akohia, i whakamatauhia, me te mahi o nga kete EB-VCA-IgA (ELISA) i hangaia e 8 Ko nga kaihanga waitohu i roto i te maakete o-whare i whakatauritehia mo te arotake mahi.Ko te whakatau ko te kete EBV-VCA-IgA (ELISA) i hangaia e Beijing Beier he rite tonu te paanga o te taatai ​​ki te EBV-VCA-IgA (ELISA) i hangaia e te reagent kawemai Oumeng, me te EBV-VCA-IgA (ELISA) Ka taea e te kete i hangaia e Beijing Beier te whakakapi i te kete kawemai mo te kitenga moata me te tirotiro i te mate pukupuku nasopharyngeal.Ko nga korero a nga kaihanga waitohu e uru ana ki te whakamatautau ka whakaatuhia i te Ripanga 1, ko nga hua whakamatautau ka whakaatuhia ki te Ripanga 2, ka whakaatuhia nga whakatau whakamatautau i te Ripanga 3.

rongo2 (3)
rongo2 (4)

Whakamutunga Whakamatau

E toru nga kete VCA-IgA recombinant-BB,HA me KSB- he rite nga paanga ki te kete o te kete paerewa. Ka taea te whakakapi mo te kete paerewa me o raatau huinga ka taea te whakamahi i te kitenga wawe me te tirotiro mo te NPC.


Wā tuku: Feb-23-2023